ContraFect Corporation
CFRXQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $45 | $36 | $23 | $18 |
| G&A Expenses | $12 | $12 | $12 | $10 |
| SG&A Expenses | $12 | $12 | $11 | $10 |
| Sales & Mktg Exp. | $0 | -$0 | -$0 | -$0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $57 | $47 | $34 | $28 |
| Operating Income | -$57 | -$47 | -$34 | -$28 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8 | $27 | $6 | $15 |
| Pre-Tax Income | -$65 | -$20 | -$28 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65 | -$20 | -$28 | -$13 |
| % Margin | – | – | – | – |
| EPS | -124.97 | -44.12 | -98.95 | -123.57 |
| % Growth | -183.3% | 55.4% | 19.9% | – |
| EPS Diluted | -124.97 | -44.12 | -98.95 | -123.57 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$65 | -$20 | -$28 | -$13 |
| % Margin | – | – | – | – |